Gene Expression in Personalized Cancer Management

Dear Colleagues,

This Special Issue, entitled "Gene Expression in Personalized Cancer Management", focuses on the emerging domain of precision oncology, which customizes therapies for individual patients based on their genetic characteristics. It explores how analyzing gene expression patterns in cancer cells can guide treatment decisions, resulting in more precise and efficacious therapies. By scrutinizing the activity levels of specific genes, researchers can pinpoint molecular markers that can be used to predict a patient's response to different drugs, thereby enabling tailored treatment approaches.

Additionally, this issue examines the pivotal role of genomic technologies, such as next-generation sequencing and microarray analysis, in decoding intricate gene expression profiles. These methodologies empower clinicians to scrutinize tumors at a molecular level, facilitating the identification of the most suitable treatment modalities and enhancing patient outcomes.

Moreover, this issue elucidates the obstacles and future trajectories in this field, including the necessity for extensive data integration, the validation of biomarkers, and the creation of innovative computational tools for data interpretation. Ultimately, "Gene Expression in Personalized Cancer Management" underscores the transformative capacity of gene expression analysis in reshaping cancer care, heralding an era of precision medicine customized to the individual genetic makeup of each patient.

Dr. Beniamin Oskar Grabarek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• precision oncology
• molecular signatures
• therapeutic decision-making
• biomarkers
• molecular profiling
• treatment response prediction
• genetic makeup
• gene expression
• microarray analysis
• next-generation sequencing